OCBCO
PTCT icon

Oversea-Chinese Banking Corp (OCBC)’s PTC Therapeutics PTCT Stock Holding History

Oversea-Chinese Banking Corp (OCBC)’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7,932
Closed -$303K – 377
2022
Q4 		$303K Buy
+7,932
New +$330K 0.02% 282

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Oversea-Chinese Banking Corp (OCBC)'s PTCT Position: Q1 2023 in Review

Oversea-Chinese Banking Corp (OCBC) sold out of PTC Therapeutics (PTCT) in Q1 2023, closing a stake of 7,932 shares — an estimated $303K sold.

Oversea-Chinese Banking Corp (OCBC) first reported a position in PTCT in Q4 2022 and held it in 1 quarter. The position peaked at $303K in Q4 2022. 202 funds tracked by Wall St. Rank hold PTCT as of Q1 2023.

  • Oversea-Chinese Banking Corp (OCBC) reported no remaining PTC Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Oversea-Chinese Banking Corp (OCBC) sold 7,932 PTC Therapeutics shares in Q1 2023, an estimated $303K.
  • Oversea-Chinese Banking Corp (OCBC) first reported a position in PTC Therapeutics in Q4 2022 and held it in 1 quarter.
  • Oversea-Chinese Banking Corp (OCBC)'s PTC Therapeutics position peaked at $303K in Q4 2022.
  • 202 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2023.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q1 2023, filed 4 May 2023.